SREBF1 and fatty liver disease: Activation of FFA4 by n-3 PUFAs inhibited hepatic steatosis, liver injury, expression of lipogenic SREBP-1c in alcohol-treated mice, and expression of Tnf-α, Cox-2, and Nlrp3 in Kupffer cells (Figure 8).